The influence of pharmacological profiles on the clinical evolution of COVID-19 patients may be significant for both decision-making and prognosis.
← all excerpts
Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy.
1
—
—